Robert Ali

Research Interests

Addiction Translational Health Outcomes

APrf Robert Ali

School of Pharmacy and Biomedical Sciences

College of Health

I'm a Public Health Physician and Specialist in Addiction Medicine. I'm an Emeritus fellow focusing on screening and brief intervention for substance use related problems in Primary Health Care. Until 2025 I was a member of the Australian National Advisory Council on Alcohol and Drugs and was a founding member of the Cochrane Alcohol and Drug Group editorial board. I served on the WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems and was the Director of the World Health Organization Collaborating Centre for Research into the Treatment of Drug and Alcohol Problems based at the University of Adelaide. Until October 2016 I was Director of Community Based Treatment at the Drug & Alcohol Services South Australia, a position I held for 30 years.

Research Projects Available
 

Project 1 - Alcohol and Other Drug Screening and Brief Advice in Antenatal Care 

Project description:  This study aims to help reduce the risks and harms of alcohol, tobacco and other drug use during pregnancy and the immediate postpartum period via effective screening and the provision of brief advice. Women attending the antenatal clinic at Lyell McEwin and Modbury Hospital will be asked to self-complete the ASSIST-Lite screening tool (on computer tablet or paper based) and be provided with brief advice by antenatal staff and relevant to their personal level of risk.

The ASSIST-Lite is a short form of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), which was developed by the World Health Organization. The findings from this study will help to determine if this is logistically appropriate and effective approach to screening and brief intervention for substance use in an antenatal setting.

Projects available for: Third Year B.Hlth.Med.Sci.

Location: Helen Mayo South

Research project start: Semester 1 only

Special requirements: NA

 

Project 2 – Validation of the ASSIST in Pitjantjatjara Language

Project description:  This project aims to develop and validate a Pitjantjatjara language adaptation of the ASSIST. The project will occur in two phases. Phase 1 (development) is already underway, which will employ small focus groups of native Pitjantjatjara speakers to help refine the screening items, and check them for cultural and language appropriateness. Once complete, the study will roll into phase 2 (validation) which will involve recruiting a separate sample of Pitjantjatjara people who have a substance use disorder to validate the adapted version of the instrument.



This study will contribute to the ever-growing cultural and alternative adaptations of the ASSIST. In practice, this study will also provide health professionals with a culturally appropriate tool that can be used for screening and brief intervention among indigenous populations in Rural Australia.

Projects available for:  Masters

Location: Helen Mayo South

Research project start: Semester 2, 2021

Special requirements: NA

Project 3 – Validation of ASSIST-Lite against current Substance Use Disorder Criteria

Project description:  This project aims to validate the ASSIST-Lite (Ultra-rapid version of the ASSIST) against DSM-5 and ICD-11 diagnostic criteria. The ASSIST-Lite has been developed for use in clinical settings where time pressures may limit the ability of health professionals to screen for all substances, such as in Emergency Departments. However, the ASSIST-Lite has yet to be validated according to the criteria outlined in the recently released DSM-5 and ICD-11. This study will recruit participants to complete a battery of substance-use screening tools and clinical interviews, including the ASSIST-Lite, and will ultimately assess the ability of the ASSIST-Lite to discriminate between groups.

The clinical and research implications for this study are far-reaching. Some primary health networks in Australia and indeed throughout the rest of the world are using ASSIST-Lite as the optimal tool for screening and brief intervention. By determining through empirical testing the discriminant validity of the ASSIST-Lite, this project will have the potential to aid clinical and policy decision-making with regard to screening and brief intervention for problematic substance use.

Projects available for: Masters

Location: Helen Mayo South

Research project start: Semester 2, 2021

Special requirements: NA

 

Project 4 – Evaluation of ASSIST training program for health professionals

Project description:  This project aims to determine the effectiveness of the current ASSIST training program in screening and brief intervention for health professionals. Specifically, this study will employ longitudinal survey design to assess changes in confidence and self-efficacy among health professionals, before and after undertaking training in the use of ASSIST and linked brief intervention.

Currently, training in administration of screening and brief intervention using the ASSIST is reliant on self-reported satisfaction scores. However, it is important and necessary for subsequent development and refinement of future training to understand the strengths and opportunities that the current treatment program presents.

Projects available for: Masters

Location: Helen Mayo South

Research project start: Semester 2, 2021

Special requirements: NA

 

 

 

Date Position Institution name
2025 - ongoing Emeritus Fellow Adelaide University
2015 - ongoing Honorary Associate Professor National Drug & Alcohol Research Centre, University of New South Wales,
2012 - ongoing Affiliate Graduate Faculty Member Virginia Commonwealth University
2002 - 2025 Clinical Associate Professor University of Adelaide
1988 - 2016 Director, Community Based Treatment Drug & Alcohol Services South Australia

Date Type Title Institution Name Country Amount
2023 Honour Officer of the Order of Australia (AO) The King's Birthday Honours List Order of Australia Australia -
2020 Award Senior Scientist Award APSAD Australian Professional Society for Alcohol and Drugs Australia -
2013 Award Mentorship Award: Princess Mother National Institute on Drug Abuse Treatment, Thailand - - -
2012 Recognition Australasian Professional Society of Alcohol and Drugs; James Rankin Orator; - - -
2005 Award Royal Australasian College of Physicians College Medal - - -
1997 Achievement South Australian Postgraduate Medical Education Association: Edward Stirling Oration - - -
1995 Award AIDS Council of South Australia Award for outstanding work in HIV and AIDS in South Australia - - -

Language Competency
English -

Date Institution name Country Title
1975 - 1981 University of Adelaide Australia MBBS

Date Title Institution Country
FAFPHM RACP Australia
FAChAM RACP Australia

Date Title Institution name Country
— Graduate Diploma in Public Health University of Adelaide -

Year Citation
2025 Stevens, M. W. R., Bertossa, S., Barry, D., Holmwood, C., Lee, K. S. K., Marsden, J., . . . Ali, R. L. (2025). ASSIST in Pitjantjatjara: Protocol for a randomised crossover validation study among Aboriginal and Torres Strait Islander Australians. Contemporary Clinical Trials Communications, 47, 101532-1-101532-8.
DOI
2025 Settumba, S., Shahbazi, J., Byrne, M., Degenhardt, L., Grebely, J., Larance, B., . . . Farrell, M. (2025). Provider costs of treating opioid dependence with extended-release buprenorphine in Australia. Drug and Alcohol Review, 44(1), 179-194.
DOI Europe PMC1
2025 Ibáñez-Martínez, N., Stevens, M. W. R., Civit-Bel, N., Moreno-Ferrer, N., Lopez-Ferré, S., Olivares-Casado, A., . . . Ali, R. (2025). Validity, reliability and clinical utility of ASSIST-Y in assessing risk of substance-related harm and dependence in Spanish male adolescents. Child and Adolescent Psychiatry and Mental Health, 19(1), 1-14.
DOI Scopus1 WoS1
2024 Ezard, N., Clifford, B., Siefried, K. J., Ali, R., Dunlop, A., McKetin, R., . . . LiMA Investigator Group. (2024). Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Addiction, 120(7), 1345-1359.
DOI Scopus8 WoS7 Europe PMC8
2024 Stevens, M. W. R., Ivers, R., Telenta, J., & Ali, R. L. (2024). Building workforce capacity to address substance use in primary health care: preliminary results from a mixed-methods pilot program. Australian Journal of Primary Health, 30(1), PY23148-1-PY23148-8.
DOI Scopus2 WoS1 Europe PMC1
2024 Stevens, M. W. R., Cooper, M., Cusack, L., Ali, R. L., & Briley, A. L. (2024). Improving the quality of antenatal screening and early intervention for alcohol and other drug use: protocol for a multi-stage approach to systems reform. Addiction Science and Clinical Practice, 19(1), 2-1-2-8.
DOI Scopus1 WoS1 Europe PMC1
2024 Farrell, M., Shahbazi, J., Chambers, M., Byrne, M., Gholami, J., Zahra, E., . . . CoLAB study team. (2024). 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. International Journal on Drug Policy, 127, 104390-1-104390-11.
DOI Scopus12 WoS12 Europe PMC10
2024 Stevens, M. W. R., Cooper, M., Cusack, L., Ali, R. L., Holmwood, C., & Briley, A. L. (2024). Screening and early intervention for substance use during pregnancy: A retrospective case note review of antenatal care records. Drug and Alcohol Review, 43(7), 1817-1828.
DOI Scopus3 WoS4 Europe PMC4
2023 Larney, S., Jones, N. R., Hickman, M., Nielsen, S., Ali, R., & Degenhardt, L. (2023). Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-2017. Addiction, 118(8), 13 pages.
DOI Scopus10 WoS9 Europe PMC11
2023 Bharat, C., Chidwick, K., Gisev, N., Farrell, M., Ali, R., & Degenhardt, L. (2023). Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022. The International journal on drug policy, 123, 104255-1-104255-12.
DOI Scopus12 WoS12 Europe PMC11
2022 Siefried, K. J., Ezard, N., Christmass, M., Haber, P., Ali, R., & The Nccred Methamphetamine And Emerging Drugs Clinical Research Network Working Group. (2022). A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia.. Drug and Alcohol Review, 41(2), 309-319.
DOI Scopus8 WoS8 Europe PMC7
2022 Stoicescu, C., Lataire, Q., Peters, K., Amon, J. J., Kamarulzaman, A., Ali, R., . . . members of the International AIDS Society–Lancet Commission on Health and Human Rights. (2022). End compulsory drug treatment in the Asia-Pacific region.. The Lancet, 399(10323), 419-421.
DOI Scopus6 Europe PMC6
2022 Zahra, E., Chen, R., Nielsen, S., Tran, A. D., Santo, T., Degenhardt, L., . . . Larance, B. (2022). Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients. Drug and Alcohol Review, 41(4), 841-850.
DOI Scopus10 WoS10 Europe PMC9
2022 Conigrave, J. H., Wilson, S., Conigrave, K. M., Chikritzhs, T., Hayman, N., Dawson, A., . . . Lee, K. S. K. (2022). ‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians. Addiction Science and Clinical Practice, 17(1), 1-11.
DOI Scopus3 WoS3 Europe PMC3
2022 Jones, N. R., Hickman, M., Nielsen, S., Larney, S., Dobbins, T., Ali, R., & Degenhardt, L. (2022). The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage study. Drug and Alcohol Dependence, 236, 109464-1-109464-9.
DOI Scopus14 WoS13 Europe PMC14
2022 Ali, R., & Stevens, M. (2022). Moving toward Voluntary Community-Based Treatment for Drug Use and Dependence.. Health and Human Rights, 24(1), 183-187.
Scopus3 WoS1 Europe PMC1
2022 Stevens, M. W. R., Harland, J., Alfred, S., & Ali, R. L. (2022). Substance use in the emergency department: Screening for risky drug use, using the ASSIST-Lite. Drug and Alcohol Review, 41(7), 1565-1576.
DOI Scopus4 WoS4 Europe PMC5
2022 Farrell, M., Shahbazi, J., Byrne, M., Grebely, J., Lintzeris, N., Chambers, M., . . . CoLAB study team. (2022). Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. International Journal of Drug Policy, 100, 103492-1-103492-10.
DOI Scopus44 WoS46 Europe PMC34
2021 Conigrave, K. M., Ali, R. L., Armstrong, R., Chikritzhs, T. N., d'Abbs, P., Harris, M. F., . . . Banks, E. (2021). Revision of the Australian guidelines to reduce health risks from drinking alcohol. Medical Journal of Australia, 215(11), 518-524.
DOI Scopus27 WoS24 Europe PMC47
2021 Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., & Minh, K. P. (2021). Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam. Drug and Alcohol Review, 40(2), 296-306.
DOI Scopus6 WoS5 Europe PMC4
2021 Nielsen, S., Sanfilippo, P., Belackova, V., Day, C., Silins, E., Lintzeris, N., . . . Larance, B. (2021). Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities. Addiction, 116(6), 1482-1494.
DOI Scopus10 WoS9 Europe PMC7
2021 Jones, N. R., Hickman, M., Larney, S., Nielsen, S., Ali, R., Murphy, T., . . . Degenhardt, L. (2021). Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: findings from the OATS retrospective cohort study. Drug and Alcohol Dependence, 218, 108354-1-108354-10.
DOI Scopus11 WoS9 Europe PMC8
2021 Jones, N. R., Nielsen, S., Farrell, M., Ali, R., Gill, A., Larney, S., & Degenhardt, L. (2021). Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes. Drug Alcohol Depend, 219, 1-8.
DOI Scopus23 WoS23 Europe PMC15
2021 Bharat, C., Larney, S., Barbieri, S., Dobbins, T., Jones, N. R., Hickman, M., . . . Degenhardt, L. (2021). The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Addiction (Abingdon, England), 116(11), 3139-3152.
DOI Scopus25 WoS24 Europe PMC16
2020 Larney, S., Jones, N., Fiellin, D. A., Nielsen, S., Hickman, M., Dobbins, T., . . . Degenhardt, L. (2020). Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia. International Journal of Epidemiology, 49(6), 1774-1775g.
DOI Scopus16 WoS16 Europe PMC14
2020 Larance, B., Degenhardt, L., Grebely, J., Nielsen, S., Bruno, R., Dietze, P., . . . Farrell, M. (2020). Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction, 115(7), 1295-1305.
DOI Scopus56 WoS64 Europe PMC50
2020 Jin, H., Larney, S., Marshall, B. D. L., Degenhardt, L., Strang, J., Hickman, M., . . . Bruneau, J. (2020). Global opioid agonist treatment: a review of clinical practices by country. Addiction, 115(12), 2243-2254.
DOI Scopus77 WoS72 Europe PMC56
2020 Larance, B., Byrne, M., Lintzeris, N., Nielsen, S., Grebely, J., Degenhardt, L., . . . CoLAB study team. (2020). Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study.. BMJ Open, 10(7), e034389-1-e034389-10.
DOI Scopus17 WoS18 Europe PMC9
2020 McKetin, R., Boden, J. M., Foulds, J. A., Najman, J. M., Ali, R., Degenhardt, L., . . . Weatherburn, D. (2020). The contribution of methamphetamine use to crime: evidence from Australian longitudinal data. Drug and Alcohol Dependence, 216, 108262-1-108262-6.
DOI Scopus28 WoS30 Europe PMC16
2019 Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., . . . McKetin, R. (2019). Responding to global stimulant use: challenges and opportunities. The Lancet, 394(10209), 1652-1667.
DOI Scopus255 WoS245 Europe PMC197
2019 Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., & Volkow, N. (2019). Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?. Addiction, 114(8), 1346-1353.
DOI Scopus60 WoS58 Europe PMC58
2019 Kalayasiri, R., Rungnirundorn, T., Ali, R., & Marsden, J. (2019). Regulation and decriminalisation of illegal substances in Thailand. Journal of Health Science and Medical Research, 37(2), 157-162.
DOI Scopus3
2019 Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., & Volkow, N. D. (2019). Response to commentaries. Addiction, 114(8), 1357-1358.
DOI
2019 Palacio, S., McMurry, H. S., Ali, R., Donenberg, T., Silva-Smith, R., Winderoff, G., . . . Hosein, P. J. (2019). DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 10(6), 1133-1139.
DOI WoS28
2018 Ali, R., & Mcketin, R. (2018). Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories?. Frontiers in Psychiatry, 9, 1-8.
DOI Scopus10 WoS10 Europe PMC7
2018 Ezard, N., Dunlop, A., Hall, M., Ali, R., McKetin, R., Bruno, R., . . . Lintzeris, N. (2018). LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. BMJ Open, 8(7), e020723.
DOI Scopus17 WoS14 Europe PMC14
2018 Larney, S., Hickman, M., Fiellin, D. A., Dobbins, T., Nielsen, S., Jones, N. R., . . . Degenhardt, L. (2018). Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study. BMJ Open, 8(8), e025204-1-e025204-6.
DOI Scopus25 WoS23 Europe PMC17
2018 Webster, S., Robinson, S., Ali, R., & Marsden, J. (2018). Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice. Journal of European CME, 7(1), 1-8.
DOI Europe PMC2
2018 Newcombe, D., Humeniuk, R., Dennington, V., & Ali, R. (2018). Participant perspectives on the Australian WHO ASSIST Phase III brief intervention for illicit drug use in a primary healthcare setting. Australian Journal of Primary Health, 24(6), 518-523.
DOI
2018 Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., Pham, K., . . . Le, G. (2018). Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam. Journal of Substance Abuse Treatment, 87, 9-15.
DOI Scopus23 WoS23 Europe PMC14
2018 Humeniuk, R., Newcombe, D., Dennington, V., & Ali, R. (2018). A randomised controlled trial of a brief intervention for illicit drug use linked to ASSIST screening in a primary healthcare setting: results from the Australian component of the World Health Organization Phase III ASSIST studies. Australian Journal of Primary Health, 24(2), 149-154.
DOI Scopus8 WoS7 Europe PMC5
2018 Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., . . . Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113(10), 1905-1926.
DOI Scopus867 WoS769 Europe PMC655
2018 Lintzeris, N., Monds, L., Rivas, C., Leung, S., Dunlop, A., Newcombe, D., . . . Ali, R. (2018). Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines. Journal of Addiction Medicine, 12(3), 234-240.
DOI Scopus34 WoS28 Europe PMC20
2018 Larance, B., Dobbins, T., Peacock, A., Ali, R., Bruno, R., Lintzeris, N., . . . Degenhardt, L. (2018). The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study. The Lancet Psychiatry, 5(2), 155-166.
DOI Scopus34 WoS28 Europe PMC26
2017 Vuong, T., Ritter, A., Nguyen, N., & Ali, R. (2017). Strengthening advocacy efforts with empirical evidence: a case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam. International Journal of Drug Policy, 49, 41-47.
DOI Scopus3 WoS3 Europe PMC3
2017 Gowing, L., Ali, R., & White, J. (2017). Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(5), 55 pages.
DOI Scopus38 WoS17 Europe PMC14
2017 Xiaolu, R., Wenwen, W., Ali, R., Xu, L., Hong, W., Min, Z., & Jiang, D. (2017). Feasibility of studying a brief intervention to help Chinese villagers with problem alcohol use after an earthquake. Alcohol and Alcoholism, 52(4), 472-476.
DOI Scopus11 WoS12 Europe PMC11
2017 Ali, R., Ramdial, J., Algaze, S., & Beitinjaneh, A. (2017). The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease. BIOMEDICINES, 5(4), 22 pages.
DOI WoS19
2017 Gowing, L., Ali, R., White, J., & Mbewe, D. (2017). Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(2), 1-95.
DOI Scopus132 WoS115 Europe PMC72
2017 Vuong, T., Nguyen, N., Le, G., Shanahan, M., Ali, R., & Ritter, A. (2017). The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia. Harm Reduction Journal, 14(1), 2-1-2-14.
DOI Scopus23 WoS20 Europe PMC10
2017 Schwartz, R., McNeely, J., Wu, L., Sharma, G., Wahle, A., Cushing, C., . . . Subramaniam, G. (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment, 76, 69-76.
DOI Scopus20 WoS16 Europe PMC17
2016 Peacock, A., Bruno, R., Larance, B., Lintzeris, N., Nielsen, S., Ali, R., . . . Degenhardt, L. (2016). Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: a retrospective 7-day diary study. Drug and Alcohol Dependence, 166, 125-133.
DOI Scopus13 WoS12 Europe PMC11
2016 Hotham, E. D., Ali, R. L., White, J. M., & Robinson, J. S. (2016). Ethical considerations when researching with pregnant substance users and implications for practice. Addictive Behaviors, 60, 242-243.
DOI Scopus3 WoS2 Europe PMC1
2016 Vuong, T., Shanahan, M., Nguyen, N., Le, G., Ali, R., Pham, K., . . . Ritter, A. (2016). Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam. Drug and Alcohol Dependence, 168, 147-155.
DOI Scopus33 WoS31 Europe PMC23
2016 McKetin, R., Gardner, J., Baker, A., Dawe, S., Ali, R., Voce, A., . . . Lubman, D. (2016). Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry Research, 238, 166-171.
DOI Scopus34 WoS35 Europe PMC26
2016 White, N., Ali, R., Larance, B., Zador, D., Mattick, R. P., & Degenhardt, L. (2016). The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film. Drug and Alcohol Review, 35(1), 76-82.
DOI Scopus25 WoS25 Europe PMC19
2016 Hotham, E., Ali, R., & White, J. (2016). Analysis of qualitative data from the investigation study in pregnancy of the ASSIST Version 3.0 (the Alcohol, Smoking and Substance Involvement Screening Test). Midwifery, 34, 183-197.
DOI Scopus11 WoS9 Europe PMC6
2016 Gowing, L., Farrell, M., Ali, R., & White, J. (2016). Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, 2016(5), 88 pages.
DOI Scopus104 WoS123 Europe PMC51
2016 Larance, B., Mattick, R., Ali, R., Lintzeris, N., Jenkinson, R., White, N., . . . Degenhardt, L. (2016). Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia. Drug and Alcohol Review, 35(1), 83-91.
DOI Scopus17 WoS12 Europe PMC12
2016 Harris, C., Ali, R., Perez-Downes, J., Baidoun, F., DeLima, M., Shah, J., . . . Makary, R. F. (2016). A Curious Case of Proximal Muscle Weakness with Eosinophilic Polymyositis.. Case reports in rheumatology, 2016, 7810916.
DOI
2016 Ali, R., Perez-Downes, J., Baidoun, F., Al Turk, B., Isache, C., Mohan, G., & Perniciaro, C. (2016). Challenges in Treating Secondary Syphilis Osteitis in an Immunocompromised Patient with a Penicillin Allergy: Case Report and Review of the Literature. CASE REPORTS IN INFECTIOUS DISEASES, 2016, 6 pages.
DOI WoS4 Europe PMC1
2015 Baidoun, F., Issa, R., Ali, R., & Al-Turk, B. (2015). Acute Unilateral Blindness from Superior Ophthalmic Vein Thrombosis: A Rare Presentation of Nephrotic Syndrome from Class IV Lupus Nephritis in the Absence of Antiphospholipid or Anticardiolipin Syndrome.. Case reports in hematology, 2015, 413975.
DOI Europe PMC8
2015 Peacock, A., Degenhardt, L., Larance, B., Cama, E., Lintzeris, N., Ali, R., & Bruno, R. (2015). A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone. Pharmacoepidemiology and Drug Safety, 24(12), 1321-1333.
DOI Scopus5 WoS5 Europe PMC2
2015 Larance, B., Lintzeris, N., Bruno, R., Peacock, A., Cama, E., Ali, R., . . . Degenhardt, L. (2015). The characteristics of a cohort who tamper with prescribed and diverted opioid medications. Journal of Substance Abuse Treatment, 58, 51-61.
DOI Scopus23 WoS22 Europe PMC17
2015 Larance, B., Dietze, P., Ali, R., Lintzeris, N., White, N., Jenkinson, R., & Degenhardt, L. (2015). The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: uptake and issues arising from changing buprenorphine formulations. Drug and Alcohol Review, 34(6), 603-610.
DOI Scopus7 WoS7 Europe PMC6
2015 Degenhardt, L., Larance, B., Bruno, R., Lintzeris, N., Ali, R., & Farrell, M. (2015). Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol. Addiction, 110(2), 226-237.
DOI Scopus20 WoS19 Europe PMC16
2015 Peacock, A., Bruno, R., Cama, E., Kihas, I., Larance, B., Lintzeris, N., . . . Degenhardt, L. (2015). Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. Drug and Alcohol Review, 34(6), 611-622.
DOI Scopus12 WoS10 Europe PMC9
2015 White, N., Flaherty, I., Higgs, P., Larance, B., Nielsen, S., Degenhardt, L., . . . Lintzeris, N. (2015). Injecting buprenorphine-naloxone film: findings from an explorative qualitative study. Drug and Alcohol Review, 34(6), 623-629.
DOI Scopus7 WoS6 Europe PMC7
2015 Gowing, L., Ali, R., Allsop, S., Marsden, J., Turf, E., West, R., & Witton, J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction, 110(6), 904-919.
DOI Scopus322 WoS291 Europe PMC237
2015 Degenhardt, L., Bruno, R., Ali, R., Lintzeris, N., Farrell, M., & Larance, B. (2015). The introduction of a potentially abuse deterrent oxycodone formulation: early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study. Drug and Alcohol Dependence, 151(.), 56-67.
DOI Scopus31 WoS30 Europe PMC24
2015 Tanguay, P., Kamarulzaman, A., Aramrattana, A., Wodak, A., Thomson, N., Ali, R., . . . Chabungbam, A. (2015). Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. Harm Reduction Journal, 12(1), 5 pages.
DOI Scopus26 WoS26 Europe PMC23
2014 Larance, B., Carragher, N., Mattick, R., Lintzeris, N., Ali, R., & Degenhardt, L. (2014). A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?. Drug and Alcohol Dependence, 142, 46-55.
DOI Scopus13 WoS13 Europe PMC12
2014 Marsden, J., Eastwood, B., Ali, R., Burkinshaw, P., Chohan, G., Copello, A., . . . Day, E. (2014). Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT). Drug and Alcohol Dependence, 139, 121-131.
DOI Scopus31 WoS28 Europe PMC21
2014 Larance, B., Lintzeris, N., Ali, R., Dietze, P., Mattick, R., Jenkinson, R., . . . Degenhardt, L. (2014). The diversion and injection of a buprenorphine-naloxone soluble film formulation. Drug and Alcohol Dependence, 136(1), 21-27.
DOI Scopus49 WoS42 Europe PMC35
2014 Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014). Pharmacotherapies for cannabis dependence. The Cochrane database of systematic reviews, 12(12), CD008940.
DOI Scopus144 WoS80 Europe PMC59
2014 Gowing, L., Farrell, M., Ali, R., & White, J. (2014). Alpha2-adrenergic agonists for the management of opioid withdrawal (review). The Cochrane database of systematic reviews, 3(3), CD002024-1-CD002024-87.
DOI Scopus89 WoS28 Europe PMC29
2014 Somogyi, A., Barratt, D., Ali, R., & Coller, J. (2014). Pharmacogenomics of methadone maintenance treatment. Pharmacogenomics, 15(7), 1007-1027.
DOI Scopus43 WoS41 Europe PMC38
2014 Alho, H., Fischer, G., Torrens, M., Maremmani, I., Ali, R., & Clark, N. (2014). Guidelines in the treatment of opiate addiction: a review and recommendation. Heroin Addiction and Related Clinical Problems, 16(4), 33-39.
Scopus3 WoS4
2013 Ali, R., Meena, S., Eastwood, B., Richards, I., & Marsden, J. (2013). Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite). Drug and Alcohol Dependence, 132(1-2), 352-361.
DOI Scopus117 WoS106 Europe PMC90
2013 Hotham, E., Ali, R., White, J., Sullivan, T., & Robinson, J. (2013). Investigation of the Alcohol, Smoking, and Substance Involvement Screening Test (the ASSIST) Version 3.0 in pregnancy. Addictive Disorders & Their Treatment, 12(3), 123-135.
DOI Scopus8 WoS6
2013 Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R., & Ferri, M. (2013). Methadone at tapered doses for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2(2), 1-68.
DOI Scopus72 WoS83 Europe PMC57
2013 McKetin, R., Lubman, D., Baker, A., Dawe, S., & Ali, R. (2013). Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry, 70(3), 319-324.
DOI Scopus179 WoS165 Europe PMC133
2013 Lintzeris, N., Leung, S., Dunlop, A., Larance, B., White, N., Rivas, G., . . . Ali, R. (2013). A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence, 131(1-2), 119-126.
DOI Scopus47 WoS41 Europe PMC31
2012 McKetin, R., Najman, J., Baker, A., Lubman, D., Dawe, S., Ali, R., . . . Mamun, A. (2012). Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction, 107(11), 1998-2008.
DOI Scopus131 WoS125 Europe PMC109
2012 Hotham, E., White, J., Ali, R., & Robinson, J. (2012). Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools. Journal of Developmental Origins of Health and Disease, 3(4), 216-223.
DOI Scopus1
2012 Vuong, T., Ali, R., Baldwin, S., & Mills, S. (2012). Drug policy in Vietnam: a decade of change?. International Journal of Drug Policy, 23(4), 319-326.
DOI Scopus50 WoS46 Europe PMC32
2012 Humeniuk, R., Ali, R., Babor, T., Formigoni, M., Boerngen de Lacerda, R., Ling, W., . . . Vendetti, J. (2012). A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction, 107(5), 957-966.
DOI Scopus184 WoS167 Europe PMC153
2012 Sarasvita, R., Tonkin, A., Utomo, B., & Ali, R. (2012). Predictive factors for treatment retention in methadone programs in Indonesia. Journal of Substance Abuse Treatment, 42(3), 239-246.
DOI Scopus58 WoS55 Europe PMC49
2011 Amato, L., Davoli, M., Vecchi, S., Ali, R., Farrell, M., Faggiano, F., . . . Chengzheng, Z. (2011). Cochrane systematic reviews in the field of addiction: what's there and what should be. Drug and Alcohol Dependence, 113(2-3), 96-113.
DOI Scopus19 WoS18 Europe PMC12
2011 Larance, B., Degenhardt, L., O'Brien, S., Lintzeris, N., Winstock, A., Mattick, R., . . . Ali, R. (2011). Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug and Alcohol Review, 30(6), 613-620.
DOI Scopus21 WoS18 Europe PMC14
2011 Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Dietze, P., . . . Horyniak, D. (2011). Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence, 118(2-3), 265-273.
DOI Scopus66 WoS62 Europe PMC51
2011 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review). The Cochrane Database of Systematic Reviews, (8), 004145-1-004145-116.
DOI Scopus221 WoS233 Europe PMC148
2011 Srisurapanont, M., Arunpongpaisal, S., Wada, K., Marsden, J., Ali, R., & Kongsakon, R. (2011). Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Progress in Neuro-psychopharmacology & Biological Psychiatry, 35(4), 959-964.
DOI Scopus80 WoS66 Europe PMC57
2011 Black, E., Larance, B., Mattick, R., Lintzeris, N., Degenhardt, L., Bruno, R., . . . Holland, R. (2011). MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA. DRUG AND ALCOHOL REVIEW, 30, 11.
2011 Marshall, K., Gowing, L., & Ali, R. (2011). Pharmacotherapies for cannabis withdrawal. Cochrane Database of Systematic Reviews, (1), 008940-1-008940-11.
DOI
2010 Ali, R., Marsden, J., Srisurapanont, M., Sunga, A., Baigent, M., & Monteiro, M. (2010). Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management. Addictive Disorders & Their Treatment, 9(4), 143-149.
DOI Scopus14 WoS10
2010 Tomas-Rossello, J., Rawson, R., Zarza, M., Bellows, A., Busse, A., Saenz, E., . . . Ling, W. (2010). United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: Treatnet. Substance Abuse, 31(4), 251-263.
DOI Scopus18 WoS11 Europe PMC12
2010 Kettler, L., Nikic, M., Newcombe, D., & Ali, R. (2010). Mood disturbance and withdrawal severity in substitution treatment for opioid dependence: Their association and impact on continued illicit drug use. Addictive Disorders & Their Treatment, 9(1), 1-7.
DOI
2010 Poznyak, V., Ali, R., Meena, S., & Du, J. (2010). Substance involvement screening test (assist) symposium. Drug and Alcohol Review, 29(Suppl 1), 59.
2010 Hotham, E., Ali, R., White, J., & Robinson, J. (2010). The alcohol, smoking and substance involvement screening test (the assist) version 3.0 in pregnancy. Drug and Alcohol Review, 29(Suppl 1), 35.
2010 Edson, M., Ali, R., & Buisman-Pijlman, F. (2010). Can recent advances in prevention and treatment of occupational blood-born enfections bring NSP in prisons a step closer. Drug and Alcohol Review, 29(Suppl 1), 25.
2010 Gowing, L., Ali, R., & White, J. (2010). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. The Cochrane Database of Systematic Reviews, (1), CD002022.
DOI Scopus25 WoS4
2009 Gowing, L., Ali, R., & White, J. (2009). Opioid antagonists with minimal sedation for opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(4), 1-47.
DOI Scopus31 WoS20 Europe PMC14
2009 Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., . . . Mattick, R. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Medical Journal of Australia, 191(3), 161-165.
DOI Scopus47 WoS43 Europe PMC28
2009 Gowing, L., Ali, R., & White, J. (2009). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(3), 1-76.
DOI Scopus190 WoS73 Europe PMC54
2009 Gowing, L., Farrell, M., Ali, R., & White, J. (2009). Alpha₂-adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, Online(2), 1-87.
DOI Scopus110 WoS46 Europe PMC20
2009 Lintzeris, N., Ali, R., Dunlop, A., Haber, P., & Wodak, A. (2009). PRESCRIPTION OPIOID POLICY: WHAT IS WORKING, NOT WORKING, AND WHAT CAN WE DO BETTER. DRUG AND ALCOHOL REVIEW, 28, A75.
2009 Gowing, L., Ali, R., & White, J. M. (2009). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), 38 pages.
DOI Scopus31 WoS43 Europe PMC33
2009 Ali, R., Burrows, D., Gowing, L., Vial, R., Walsh, N., Onyancha, P., & Finnerty, E. (2009). Review of Global Policy Architecture and Country Level Practice on HIV/AIDS and Drug Treatment.
2009 Mcketin, R., Ross, J., Najman, J., Baker, A., Lubman, D., Dawe, S., . . . Mamun, A. (2009). TREATMENT OUTCOMES FOR METHAMPHETAMINE USE: FINDING FROM THE METHAMPHETAMINE TREATMENT EVALUATION STUDY (MATES). DRUG AND ALCOHOL REVIEW, 28, A76-A77.
2008 Humeniuk, R., Ali, R., Babor, T., Farrell, M., Formigoni, M., Jittiwutikarn, J., . . . Simon, S. (2008). Validation of the alcohol, smoking and substance involement screening test (ASSIST). Addiction, 103(6), 1039-1047.
DOI Scopus918 WoS857 Europe PMC781
2008 Gibson, A., Degenhardt, L., Mattick, R., Ali, R., White, J., & O'Brien, S. (2008). Exposure to opioid maintenance treatment reduces long-term mortality. Addiction, 103(3), 462-468.
DOI Scopus166 WoS158 Europe PMC132
2008 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. The Cochrane Database of Systematic Reviews, 2009(2), 1-102.
DOI Scopus246 WoS135 Europe PMC104
2008 Somogyi, A., Larsen, M., Abadi, R., Jittiwutikarn, J., Ali, R., & White, J. (2008). Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology, 66(5), 640-647.
DOI Scopus19 WoS20 Europe PMC15
2008 Lawrinson, P., Ali, R., Buarvirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., . . . Zhao, C. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103(9), 1484-1492.
DOI Scopus203 WoS190 Europe PMC168
2008 Hotham, E., Ali, R., White, J., & Robinson, J. (2008). Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia. Australian & New Zealand Journal of Obstetrics & Gynaecology, 48(3), 248-254.
DOI Scopus41 WoS36 Europe PMC31
2008 Wodak, A., Ali, R., Sansom, L., & Henry, D. (2008). Ensuring the safety of new medications and devices: are naltrexone implants safe?. Medical Journal of Australia, 188(8), 438-439.
DOI Scopus10 WoS8 Europe PMC3
2008 McKetin, R., Kozel, N., Douglas, J., Ali, R., Vicknasingam, B., Lund, J., & Li, J. (2008). The rise of methamphetamine in southeast and East Asia. Drug and Alcohol Review, 27(3), 220-228.
DOI Scopus134 WoS111 Europe PMC87
2006 O'Brien, S., Mattick, R., White, J., Breen, C., Kimber, J., Ritter, A., & Lintzeris, N. (2006). Maintenance pharmacotherapy for opioid dependence and SF-36 Health status: a comparison with general population norms and other chronic disorders. Addictive Disorders & Their Treatment, 5(4), 155-164.
DOI Scopus17 WoS15
2006 Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 83(2), 174-180.
DOI Scopus124 WoS114 Europe PMC88
2006 Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(Issue 2. Art. No. CD002022), 1-26.
DOI Scopus43 WoS45 Europe PMC17
2006 Kornor, H., Waal, H., & Ali, R. (2006). Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling. Drug and Alcohol Review, 25(2), 123-130.
DOI Scopus10 WoS11 Europe PMC7
2006 Gowing, L., & Ali, R. (2006). The place of detoxification in treatment of opioid dependence. Current Opinion in Psychiatry, 19(3), 266-270.
DOI Scopus24 WoS18 Europe PMC18
2006 Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists with minimal sedation for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(1AR CD002021DI ARTN CD002021), 2021.
DOI Scopus14 WoS4 Europe PMC8
2006 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine (online), 21(2), 193-195.
DOI Scopus90 WoS80 Europe PMC65
2006 Shanahan, M., Doran, C., Digiusto, E., Bell, J., Lintzeris, N., White, J., . . . Gilmour, S. (2006). A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addictive Behaviors, 31(3), 371-387.
DOI Scopus21 WoS17 Europe PMC14
2006 Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). Short-term outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addictive Disorders and their Treatment, 5(3), 133-143.
DOI Scopus25 WoS24
2005 Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2005). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), CD003409.
DOI Scopus74 WoS38 Europe PMC45
2005 Humeniuk, R., & Ali, R. (2005). The first methadone clinic in Beijing. Drug and Alcohol Review, 24(3), 285-287.
DOI Scopus6 WoS5 Europe PMC5
2005 Reece, A. S. (2005). HIV in injecting drug users in Asian countries: naltrexone implants are set to supersede harm minimisation.. BMJ (Clinical research ed.), 330(7483), 147.
DOI
2005 Wodak, A., Ali, R., & Farrell, M. (2005). HIV in injecting drug users in Asian countries - Reply. British Medical Journal, 330(7483), 147.
DOI
2005 Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2005). The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 24(5), 411-418.
DOI Scopus219 WoS204 Europe PMC157
2005 Darke, S., Ross, J., Teesson, M., Ali, R., Cooke, R., Ritter, A., & Lynskey, M. (2005). Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 28(3), 255-263.
DOI Scopus87 WoS77 Europe PMC58
2005 Digiusto, E., Lintzeris, N., Breen, C., Kimber, J., Mattick, R., Bell, J., . . . Saunders, J. (2005). Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project. Addictive Behaviors, 30(3), 443-456.
DOI Scopus18 WoS17 Europe PMC14
2005 Farrell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16S(SUPPL. 1), S67-S75.
DOI Scopus55 WoS54
2005 Newcombe, D., Humeniuk, R., & Ali, R. (2005). Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug and Alcohol Review, 24(3), 217-226.
DOI Scopus252 WoS231 Europe PMC211
2004 Ling, W., Farrell, M., & Ali, R. (2004). Cochrane systematic reviews: time for an introduction and appraisal. Drug and Alcohol Dependence, 73(3), 217-218.
DOI Scopus6 WoS6 Europe PMC5
2004 Jittiwutikarn, J., Ali, R., White, J., Bochner, F., Somogyi, A., & Foster, D. (2004). Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. British Journal of Clinical Pharmacology, 58(5), 536-541.
DOI Scopus20 WoS17 Europe PMC11
2004 Wodak, A., Ali, R., & Farrell, M. (2004). HIV in injecting drug users in Asian countries. British Medical Journal, 329(7468), 697-698.
DOI Scopus13 WoS7 Europe PMC7
2004 Gowing, L., Farrell, M., Ali, R., & White, J. (2004). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (4), CD002024.
DOI Scopus26 WoS9 Europe PMC13
2004 Kaya, C. Y., Tugai, Y., Filar, J. A., Agrawal, M., Ali, R., Linda, R., & Cooke, R. (2004). Heroin users in Australia : population trends. Drug and alcohol review, 23(1), 107-116.
DOI Scopus17 WoS10 Europe PMC4
2004 Gowing, L., Ali, R., & White, J. (2004). Buprenorphine for the management of opioid withdrawal.. Cochrane Database of Systematic Reviews Online, (4), CD002025.
DOI Scopus34 Europe PMC16
2004 Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection.. Cochrane database of systematic reviews (Online), (4), CD004145.
DOI Scopus34 Europe PMC25
2004 Humeniuk, R., & Ali, R. (2004). Amphetamines in Asia: the value of information networks. Drug and Alcohol Review, 23(2), 235-237.
DOI Scopus2
2004 Longo, M. C., Henry-Edwards, S. M., Humeniuk, R. E., Christie, P., & Ali, R. L. (2004). Impact of the heroin 'drought' on patterns of drug use and drug-related harms. Drug and Alcohol Review, 23(2), 143-150.
DOI Scopus23 WoS22 Europe PMC17
2004 Humeniuk, R., Ali, R., & Ling, W. (2004). Substance use and treatment options in Cambodia. Drug and Alcohol Review, 23(3), 365-367.
DOI Scopus2 WoS2 Europe PMC2
2004 Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2004). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), CD003409.
DOI Europe PMC4
2004 Humeniuk, R., & Ali, R. (2004). Asia Pacific Column. Announcement of column on capacity building in the Asia Pacific region.. Drug and Alcohol Review, 23(1), 133-134.
DOI
2003 Gowing, L., Farrell, M., Ali, R., & White, J. (2003). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002024.
DOI Scopus6 Europe PMC15
2003 Amato, L., Davoli, M., Ferri, M., & Ali, R. (2003). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD003409.
DOI Scopus101 Europe PMC4
2003 Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology, 6(4), 347-352.
DOI Scopus147 WoS121 Europe PMC98
2003 Humeniuk, R., Ali, R., McGregor, C., & Darke, S. (2003). Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction, 98(4), 413-418.
DOI Scopus42 WoS38 Europe PMC28
2003 Ali, R., Thomas, P., White, J., McGregor, C., Danz, C., Gowing, L., . . . Athanasos, P. (2003). Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity. Drug and Alcohol Review, 22(4), 425-431.
DOI Scopus11 WoS11 Europe PMC8
2003 Mattick, R., Ali, R., White, J., O'Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98(4), 441-452.
DOI Scopus250 WoS219 Europe PMC183
2003 Doran, C., Shanahan, M., Mattick, R., Ali, R., White, J., & Bell, J. (2003). Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug and Alcohol Dependence, 71(3), 295-302.
DOI Scopus99 WoS83 Europe PMC74
2002 Doverty, M., White, J., Somogyi, A., Bochner, F., Ali, R., & Ling, W. (2002). Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001;90 : 91-96). Pain, 99(3), 609-610.
DOI WoS1
2002 Farrell, M., Marsden, J., Ali, R., & Ling, W. (2002). Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction, 97(7), 771-772.
DOI Scopus104 WoS93 Europe PMC77
2002 Gowing, L., Henry-Edwards, S., Irvine, R., & Ali, R. (2002). The health effects of ecstacy: a literature review. Drug and Alcohol Review, 21(1), 53-63.
DOI Scopus130 Europe PMC91
2002 Gowing, L., Ali, R., & White, J. (2002). Which substitution pharmacotherapy is most effective in treating opioid dependence?. Medical Journal of Australia, 176(10), 493-494.
DOI
2002 Ali, R., Awwad, E., Babor, T., Bradley, F., Butau, T., Farrell, M., . . . Vendetti, J. (2002). The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction, 97(9), 1183-1194.
DOI Scopus1634 WoS1493 Europe PMC1313
2002 White, J., Danz, C., Kneebone, J., La Vincente, S., Newcombe, D., & Ali, R. (2002). Relationship between LAAM-methadone preference and treatment outcomes. Drug and Alcohol Dependence, 66(3), 295-301.
DOI Scopus20 WoS18 Europe PMC16
2002 Gowing, L., Farrell, M., Ali, R., & White, J. (2002). a₂-Adrenergic agonists in opioid withdrawal. Addiction, 97(1), 49-58.
DOI Scopus63 WoS49 Europe PMC49
2002 McGregor, C., Ali, R., Lokan, R., Christie, P., & Darke, S. (2002). Accidental fatalities among heroin users in South Australia, 1994-1997: Toxicological findings and circumstances of death. Addiction Research and Theory, 10(4), 335-346.
DOI Scopus22 WoS14
2002 McGregor, C., Ali, R., White, J., Thomas, P., & Gowing, L. (2002). A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence, 68(1), 5-14.
DOI Scopus35 WoS34 Europe PMC27
2002 Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), CD002025-1-CD002025-22.
DOI Scopus21 Europe PMC5
2002 Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal.. Cochrane Database of Systematic Reviews Online, (2), CD002025.
DOI Scopus31 Europe PMC18
2002 Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists with minimal sedation for opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (2), CD002021.
DOI Scopus15 Europe PMC5
2002 Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: a literature review. DRUG AND ALCOHOL REVIEW, 21(1), 53-63.
DOI WoS104
2002 Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.. Cochrane Database of Systematic Reviews Online, (2), CD002022.
DOI Scopus16 Europe PMC6
2002 Bammer, G., Hall, W., Hamilton, M., & Ali, R. (2002). Harm minimization in a prohibition context - Australia. Annals of the American Academy of Political and Social Science, 582(JULY), 80-93.
DOI Scopus14 WoS11
2002 Amato, L., Davoli, M., Ferri, M., & Ali, R. (2002). Methadone at tapered doses for the management of opioid withdrawal.. The Cochrane database of systematic reviews, (1), CD003409.
DOI Europe PMC5
2002 Amato, L., Davoli, M., Ferri, M., & Ali, R. (2002). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane Database Syst Rev, (1), CD003409.
DOI
2001 McGregor, C., Ali, R., Christie, P., & Darke, S. (2001). Overdose among heroin users: Evaluation of an intervention in South Australia. Addiction Research and Theory, 9(5), 481-501.
DOI Scopus17 WoS16
2001 Gowing, L., Ali, R., & White, J. (2001). Buprenorphine for the management of opioid withdrawal. Praxis, 90(44), 1934.
2001 Mattick, R. P., Ali, R., Auriacombe, M., Davoli, M., Faggiano, F., Farrell, M., . . . Ling, W. (2001). Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcome. Alcohol and Alcoholism, 36(2), 109-111.
DOI Scopus4 WoS1 Europe PMC1
2001 Gowing, L., Farrell, M., Ali, R., & White, J. (2001). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane Database of Systematic Reviews Online, (1), CD002024.
DOI Scopus20 Europe PMC20
2001 Gowing, L., Ali, R., & White, J. (2001). Opioid antagonists under sedation or anaesthesia for opioid withdrawal.. Cochrane Database of Systematic Reviews Online, (1), CD002022.
DOI Scopus12 Europe PMC1
2001 Doverty, M., White, J., Somogyi, A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90(01-Feb), 91-96.
DOI Scopus276 WoS223 Europe PMC203
2000 Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), 1-2.
DOI Scopus15 Europe PMC5
2000 Gowing, L., Ali, R., & White, J. (2000). The management of opioid withdrawal. Drug and Alcohol Review, 19(3), 309-318.
DOI Scopus19 WoS16
2000 Gowing, L., Ali, R., & White, J. (2000). Systematic review processes and the management of opioid withdrawal. Australian and New Zealand Journal of Public Health, 24(4), 427-431.
DOI Scopus5 WoS3 Europe PMC4
2000 Single, E., Christie, P., & Ali, R. (2000). The impact of cannabis decriminalisation in australia and the united states. Journal of Public Health Policy, 21(2), 157-186.
DOI Scopus77 WoS61 Europe PMC28
2000 Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Praxis, 89(44), 1810-1811.
2000 Ali, R., McGregor, C., Christie, P., & Darke, S. (2000). Heroin overdose: Responding to the epidemic. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 34(s1), A1-A2.
DOI WoS1
2000 Christie, P., & Ali, R. (2000). Offences under the Cannabis Expiation Notice scheme in South Australia. Drug and Alcohol Review, 19(3), 251-256.
DOI Scopus19 WoS17
2000 Allsop, S. J., Ali, R. L., & Edmonds, C. A. (2000). A training, authorisation and review process for methadone prescribers. Journal of Maintenance in the Addictions, 1(4), 15-25.
DOI Scopus4
2000 Ali, R. (2000). Special section: Cannabis expiation in South Australia - Introduction. DRUG AND ALCOHOL REVIEW, 19(3), 249.
WoS2
1999 Ali, R., Auriacombe, M., Casas, M., Cottler, L., Farrell, M., Kleiber, D., . . . Ward, P. (1999). Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts. Sucht, 45(3), 160-170.
Scopus21
1999 Ali, R. L., & Quigley, A. J. (1999). Accidental drug toxicity associated with methadone maintenance treatment. Medical Journal of Australia, 170(3), 100-101.
DOI Scopus5 WoS5 Europe PMC3
1999 Lenton, S., McDonald, D., Ali, R., & Moore, T. (1999). Laws applying to minor cannabis offences in Australia and their evaluation. International Journal of Drug Policy, 10(4), 299-303.
DOI Scopus4
1999 Vincent, N., Shoobridge, J. A., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users
seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review, 18(1), 63-73.
1999 Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia.. Drug and Alcohol Review, 18(1), 63-73.
DOI Scopus19 WoS17
1999 Wolff, K., Farrell, M., Marsden, J., Monteiro, M., Ali, R., Welch, S., & Strang, J. (1999). A review of biological indicators of illicit drug use, practical considerations and clinical usefulness.. Addiction, 94(9), 1279-1298.
DOI Scopus160 WoS134 Europe PMC98
1998 Gaughwin, M., Solomon, P., & Ali, R. (1998). Correlates of retention on the South Australian methadone program 1981-91. Australian New Zealand Journal of Public Health, 22(7), 771-776.
DOI Scopus11 WoS10 Europe PMC9
1998 Gowing, L., Ali, R., Christie, P., & White, J. (1998). Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review, 17(4), 445-452.
DOI WoS2 Europe PMC1
1998 Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1998). Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug and Alcohol Review, 17(2), 187-195.
DOI Scopus30 WoS28 Europe PMC24
1998 Mcgregor, C., Darke, S., Ali, R., & Christie, P. (1998). Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions. Addiction, 93(5), 701-711.
DOI Scopus187 WoS174 Europe PMC134
1997 MacDonald, M., Wodak, A. D., Ali, R., Crofts, N., Cunningham, P. H., Dolan, K. A., . . . Kaldor, J. M. (1997). HIV prevalence and risk behaviour in needle exchange attenders: A national study. Medical Journal of Australia, 166(5), 237-240.
DOI Scopus64 WoS62 Europe PMC36
1997 Ali, R. (1997). America's drug war debacle. ADDICTION, 92(12), 1790-1791.
1996 Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996). Heroin overdose: the case for take-home naltrexone. British Medical Journal, 312(7044), 1435-1436.
DOI Scopus143 WoS130 Europe PMC96
1996 White, J., Ryan, C., & Ali, R. (1996). Improvements in retention rates and changes in client groups with methadone maintenance streaming.. Drug and Alcohol Review, 15(1), 83-88.
DOI Scopus17 WoS14 Europe PMC11
1995 Gaughwin, M. D., & Ali, R. (1995). HIV infection among injecting drug users in the South Australian methadone program. Medical Journal of Australia, 162(5), 242-244.
DOI Scopus6 WoS5 Europe PMC2
1994 Waddell, R. G., Gaughwin, M., Dodding, J., Ali, R., & Crofts, N. (1994). Hepatitis C and the history of injecting drug use in South Australia [3]. Medical Journal of Australia, 161(4), 286-287.
DOI Scopus6 WoS7 Europe PMC2
1994 GAUGHWIN, M., DODDING, J., & ALI, R. (1994). HEPATITIS-C AND THE HISTORY OF INJECTING DRUG-USE IN SOUTH AUSTRALIA - REPLY. MEDICAL JOURNAL OF AUSTRALIA, 161(4), 286.
DOI WoS7 Europe PMC2
1994 ALI, R. L., & CORMACK, S. M. (1994). In‐patient treatment for the alcohol‐dependent person: a public health perspective. Drug and Alcohol Review, 13(2), 195-202.
DOI Scopus4 Europe PMC1
1994 White, J. M., Dyer, K. R., Ali, R. L., Gaughwin, M. D., & Cormack, S. (1994). Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug and Alcohol Dependence, 34(2), 113-119.
DOI Scopus12 WoS11 Europe PMC10
1993 Gaughwin, M., Kliewer, E., Ali, R., Faulkner, C., Wodak, A., & Anderson, G. (1993). The prescription of methadone for opiate dependence in Australia, 1985-1991. Medical Journal of Australia, 159(2), 107-108.
DOI Scopus5 WoS5 Europe PMC4
1992 Weller, D. P., Litt, J. C. B., Pols, R. G., Ali, R. L., Southgate, D. O., & Harris, R. D. (1992). Drug and alcohol related health problems in primary care - What do GPs think?. Medical Journal of Australia, 156(1), 43-48.
DOI Scopus60 WoS60 Europe PMC34
1991 Gaughwin, M. D., Douglas, R. M., Liew, C., Davies, L., Mylvaganam, A., Treffke, H., . . . Ali, R. (1991). HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS, 5(7), 845-851.
DOI Scopus44 WoS29 Europe PMC22
1991 Gaughwin, M. D., Gowans, E., Ali, R., & Burrell, C. (1991). Bloody needles: The volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS, 5(8), 1025-1027.
DOI Scopus47 WoS51 Europe PMC26
1990 Gaughwin, M. D., Ryan, P., Treffke, H., Lee, M., & Ali, R. (1990). Can I buy a syringe? The availability of needles and syringes to intravenous drug users in Adelaide. Medical Journal of Australia, 153(9), 569.
DOI Scopus1 WoS3 Europe PMC1
1990 Douglas, R. M., Gaugwhin, M. D., Ali, R. L., Davies, L. M., Mylvaganam, A., & Liew, C. Y. (1990). Risk of transmission of the human immunodeficiency virus in the prison setting. Medical Journal of Australia, 153(7), 434.
DOI
1990 Gaughwin, M. D., Douglas, R. M., Davies, L., Mylvaganam, A., Liew, C., & Ali, R. (1990). PREVENTING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AMONG PRISONERS: PRISONERS' AND PRISON OFFICERS' KNOWLEDGE OF HIV AND THEIR ATTITUDES TO OPTIONS FOR PREVENTION. Community Health Studies, 14(1), 61-64.
DOI Scopus2 WoS1
1989 Douglas, R. M., Gaughwin, M. D., Ali, R. L., Davies, L. M., Mylvaganam, A., & Liew, C. Y. (1989). Risk of transmission of the human immunodeficiency virus in the prison setting.. Medical Journal of Australia, 150(12), 722.
DOI Scopus11 WoS8
- Stevens, M. W. R., Bertossa, S., Dominic, B., Holmwood, C., Lee, K. S. K., Marsden, J., . . . Ali, R. (n.d.). Assist in Pitjantjatjara: An Order-Randomised Validation Study Protocol.

Year Citation
2014 Gowing, L., Ali, R., Dunlop, A., Farrell, M., & Lintzeris, N. (2014). National Guidelines for Medication-Assisted Treatment of Opioid Dependence. Commonwealth of Australia, Canberra.
2009 Mattick, R., Ali, R., & Lintzeris, N. (Eds.) (2009). Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines. Informa.

Year Citation
2020 Harland, J., Henry-Edwards, S., Gowing, L., & Ali, R. (2020). Brief Intervention for Illicit Drug Use. In Textbook of Addiction Treatment International Perspectives (pp. 655-671). Springer International Publishing.
DOI
2016 Ali, R., Gowing, L., & Harland, J. (2016). The Ultrarapid Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST-Lite) and Implications for Neuropathology. In V. Preedy (Ed.), Neuropathology of Drug Addictions and Substance Misuse, Volume 1: Foundations of Understanding, Tobacco, Alcohol, Cannabinoids and Opioids (Vol. 1, pp. 649-659). United Kingdom: Elsevier.
DOI Scopus1
2015 Ali, R., Gowing, L., & Harland, J. (2015). Screening and brief interventions. In P. Haber, C. Day, & M. Farrell (Eds.), Addiction Medicine: Principles and Practice (pp. 126-142). Melbourne: IP Communications.
2015 Harland, J., Gowing, L., & Ali, R. (2015). Brief Interventions for Illicit Drug Users.. In G. Carrà, N. el-Guebaly, & M. Galanter (Eds.), Textbook of Addiction Treatment: International Perspectives (pp. 293-312). Springer Milan.
DOI
2012 Ali, R. L., Meena, S., & Gowing, L. (2012). Effective responses in general health and other mainstream services. In S. allsop, & N. lee (Eds.), Perspectives on Ampthetamine-Type Stimulants (pp. 213-240).
2009 Lintzeris, N., Clark, N., Muhleisen, P., Ritter, A., Ali, R., Bell, J., . . . White, J. (2009). National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence. In R. Mattick, R. Ali, & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 390-445). New York, USA: Informa.
2009 Bell, J., Kimber, J., Lintzeris, N., White, J., Monheit, B., Henry-Edwards, S., . . . Quigley, A. (2009). Clinical guidelines and procedures for the use of naltrexone in the management of opioid dependence. In R. Mattick, R. Ali, & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 446-474). New York, USA: Informa.
2009 Henry-Edwards, S., Gowing, L., White, J., Ali, R., Bell, J., Brough, J., . . . Quigley, A. (2009). Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence. In R. Mattick, R. Ali, & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 354-389). New York, USA: Informa.

Year Citation
2023 Briley, A., Ali, R., Cooper, M., Cusack, L., & Stevens, M. W. R. (2023). Screening for alcohol and other drug use during pregnancy: Exploring rates of detection and intervention during antenatal care visits. In DRUG AND ALCOHOL REVIEW Vol. 42 (pp. S47). WILEY.
WoS1
2023 Lee, K. S. K., Wilson, S., Ali, R., Stevens, M. W. R., Hides, L., Ward, J., . . . Conigrave, K. M. (2023). Symposium: Digital innovation in alcohol and other drug use research and practice. In DRUG AND ALCOHOL REVIEW Vol. 42 (pp. S5-S6). WILEY.
2023 Ali, R., & Stevens, M. W. R. (2023). Digital interventions for substance use disorders: Challenges and opportunities from the lens of primary health. In DRUG AND ALCOHOL REVIEW Vol. 42 (pp. S6-S7). WILEY.
2022 Stevens, M., Barry, D., Bertossa, S., Thompson, M., & Ali, R. (2022). Translation and cultural adaptation of the World Health Organization's Alcohol, Smoking and Substance Involvement Screening Test into Pitjantjatjara. In DRUG AND ALCOHOL REVIEW Vol. 41 (pp. S129). WILEY.
2021 Farrell, M., Shahbazi, J., Byrne, M., Larance, B., Lintzeris, N., Nielsen, S., . . . Degenhardt, L. (2021). OVERVIEW AND FINDINGS OF THE COLAB STUDY: AN OPEN-LABEL IMPLEMENTATION STUDY OF SUBLOCADE TREATMENT IN SPECIALIST AND PRIMARY CARE SETTINGS IN AUSTRALIA. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S25). WILEY.
2021 Jones, N. R., Hickman, M., Larney, S., Nielsen, S., Ali, R., Dobbins, T., . . . Degenhardt, L. (2021). INCIDENCE OF FATAL AND NON-FATAL DRUG OVERDOSE AMONG PEOPLE WITH A HISTORY OF OPIOID DEPENDENCE INCREASE IN THE FIRST FOUR WEEKS OF TREATMENT CESSATION: RETROSPECTIVE LINKAGE STUDY. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S87). WILEY.
2021 Farrell, M., Shahbazi, J., Byrne, M., Larance, B., Lintzeris, N., Nielsen, S., . . . Degenhardt, L. (2021). AN OPEN-LABEL, MULTICENTRE, SINGLE-ARM TRIAL OF MONTHLY INJECTIONS OF EXTENDED RELEASE BUPRENORPHINE IN PEOPLE WITH OPIOID USE DISORDER: THE COLAB STUDY. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S71-S72). WILEY.
2021 Stevens, M. W. R., Gowing, L., Harland, J., Alfred, S., & Ali, R. (2021). SCREENING FOR RISKY SUBSTANCE USE IN EMERGENCY DEPARTMENT PRESENTATIONS: A PILOT INVESTIGATION OF ASSIST-LITE TO INVESTIGATE THE CHARACTERISTICS OF SUBSTANCE USERS ATTENDING THE ROYAL ADELAIDE HOSPITAL. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S135-S136). WILEY.
2021 Ezard, N., Dunlop, A. J., Liaw, W., Mcdonough, M., Ali, R., White, J., . . . Lintzeris, N. (2021). Covid and the lima study, a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. In Proceedings of the APSAD Scientific Drug and Alcohol Conference, as published in Drug and Alcohol Review Vol. 40 (pp. S12-S13). online: Wiley.
DOI WoS1
2021 Siefried, K. J., Ezard, N., Christmass, M., Hayllar, J., & Ali, R. (2021). TOWARDS AN AUSTRALIAN CLINICAL RESEARCH NETWORK FOR METHAMPHETAMINE AND EMERGING DRUGS - OUTCOMES OF THE NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS METHAMPHETAMINE AND EMERGING DRUGS CLINICAL RESEARCH NETWORK WORKING GROUP 2018-21. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S133-S134). WILEY.
2020 Husnain, M., Komanduri, K., Ramdial, J., Lekakis, L. J., Wang, T. P., Goodman, M., . . . Jimenez, A. M. (2020). Pre-transplant molecular minimal residual disease (MMRD) is associated with inferior outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38 (pp. 2 pages). ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS.
2019 Siefried, K. J., Nguyen, Q. A., Ezard, N., Christmass, M., & Ali, R. (2019). A RAPID CLINICAL RESEARCH PRIORITY SETTING STUDY FOR SUBSTANCE USE DISORDER DUE TO METHAMPHETAMINE AND EMERGING DRUGS OF CONCERN IN AUSTRALIA. In DRUG AND ALCOHOL REVIEW Vol. 38 (pp. S94). WILEY.
WoS1
2018 Ali, R., Gowing, L. R., & Harland, J. (2018). EMERGENCY ROOM ATTENDERS: WHAT PROPORTION HAVE A SUBSTANCE USE PROBLEM AND SLIP THROUGH THE CRACKS?. In DRUG AND ALCOHOL REVIEW Vol. 37 (pp. S18). WILEY.
WoS1
2018 Ali, R., & Newcombe, D. (2018). WORKSHOP: SCALING UP SCREENING, BRIEF INTERVENTION AND REFERRAL TO TREATMENT IN PRIMARY HEALTH CARE: HOW THE ASSIST CAN HELP YOU. In DRUG AND ALCOHOL REVIEW Vol. 37 (pp. S16). WILEY.
2017 Peacock, A., Bruno, R., Larance, B., Lintzeris, N., Ali, R., Oen, D., . . . Degenhardt, L. (2017). Same-day use of opioids and depressants: A retrospective diary study. In Abstracts of the 78th College on Problems of Drug Dependence Annual Meeting (CPDD 2016) as published in Drug and Alcohol Dependence Vol. 171 (pp. e161). Palm Springs, California: Elsevier.
DOI
2014 Larance, B., Degenhardt, L., Mattick, R., Ali, R., & Lintzeris, N. (2014). Australian post-marketing surveillance studies, 2012. In Drug and Alcohol Dependence Vol. 140 (pp. e115-e116). Elsevier BV.
DOI
2014 ali, R., & Gowing, L. (2014). Translating evidence into the best outcomes in addiction treatment. In CJAM Canadian Journal of Addiction Medicine Vol. 5 (pp. 20). Canadian Society of Addiction Medicine.
2012 Ali, R. (2012). 2012 JAMES RANKIN ORATION. In DRUG AND ALCOHOL REVIEW Vol. 31 (pp. 74). WILEY-BLACKWELL.
2012 Ali, R. (2012). PRESENTATION 1-CONTEXT TO THE REVISION OF THE NATIONAL POLICY AND GUIDELINES. In DRUG AND ALCOHOL REVIEW Vol. 31 (pp. 7). WILEY-BLACKWELL.
2011 Ali, R., & Lintzeris, N. (2011). PRESENTATION 2-CLINICAL GUIDELINES FOR THE USE OF SUBOXONE SUBLINGUAL FILM. In DRUG AND ALCOHOL REVIEW Vol. 30 (pp. 54). WILEY-BLACKWELL.
2009 Ali, R. (2009). RECENT INTERNATIONAL EXPERIENCE IN OPIOID SUBSTITUTION THERAPY. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 43 (pp. A18). SAGE PUBLICATIONS LTD.
2002 Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2002). A factor structure of methamphetamine psychotic symptoms. In EUROPEAN NEUROPSYCHOPHARMACOLOGY Vol. 12 (pp. S257-S258). ELSEVIER SCIENCE BV.

Year Citation
2023 Lee, K. S. K., Wilson, S., Perry, J., Conigrave, J. H., Zheng, C., Dale, L., . . . Conigrave, K. M. (2023). Tailored brief interventions and flexible content management systems, To enable the Grog App to be adapted across language and context. Poster session presented at the meeting of Abstracts from the Australasian Professional Society on Alcohol and Other Drugs Conference as published in Drug and Alcohol Review. United Kingdom: Wiley.
DOI
2023 Farrell, M., Shahbazi, J., Chambers, M., Byrne, M., Gholami, J., Zahra, E., . . . Degenhardt, L. (2023). Ninety-six week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a singlearm trial. Poster session presented at the meeting of Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference (APSAD 2023), as published in Drug and Alcohol Review. Adelaide, SA: Wiley.
DOI
2021 Jones, N. R., Nielsen, S., Farrell, M., Ali, R., Gill, A., Larney, S., & Degenhardt, L. (2021). RETENTION OF OPIOID AGONIST TREATMENT PRESCRIBERS ACROSS NEW SOUTH WALES, AUSTRALIA, 2001-2018: IMPLICATIONS FOR TREATMENT SYSTEMS AND POTENTIAL IMPACT ON CLIENT OUTCOMES. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2021 Bharat, C., Larney, S., Barbieri, S., Dobbins, T., Jones, N. R., Hickman, M., . . . Degenhardt, L. (2021). The effect of prescriber, treatment, and client characteristics on retention in opioid agonist treatment: A 15-year retrospective cohort study. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.
2021 Bharat, C., Larney, S., Barbieri, S., Dobbins, T., Jones, N. R., Hickman, M., . . . Degenhardt, L. (2021). THE EFFECT OF PERSON, TREATMENT AND PRESCRIBER CHARACTERISTICS ON RETENTION IN OPIOID AGONIST TREATMENT: A 15-YEAR RETROSPECTIVE COHORT STUDY. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2019 Harland, J., Ali, R., & Gowing, L. (2019). RESEARCH INTO PRACTICE: DEVELOPMENT OF THE ASSIST-LITE IN THE EMERGENCY DEPARTMENT TRAINING RESOURCE. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2019 Larance, B., Degenhardt, L., Grebely, J., Nielsen, S., Bruno, R., Dietze, P. M., . . . Farrell, M. (2019). Perceptions of extended-release buprenorphine injections for opioid dependence prior to availability in Australia: a cross-sectional survey of people who use opioids regularly. Poster session presented at the meeting of Drug and Alcohol Review. Hobart: Wiley.
2017 Lintzeris, N., Dunlop, A. J., Haber, P. S., Ali, R., Kim, S., & Tiberg, F. (2017). LONG-TERM SAFETY, TOLERABILITY AND EFFECTIVENESS OF WEEKLY AND MONTHLY BUPRENORPHINE DEPOTS FOR OPIOID USE DISORDER. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2016 Ezard, N., Dunlop, A. J., Carr, A., McKetin, R., Ali, R., White, J., . . . Lintzeris, N. (2016). A randomised, double-blind, placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence: The LiMA study protocol. Poster session presented at the meeting of Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference, as published in Drug and Alcohol Review. Sydney, Australia: WILEY.
DOI
2016 Lintzeris, N., Monds, L., Rivas, G., Leung, S., Dunlop, A. J., Newcombe, D., . . . Ali, R. (2016). TRANSFERRING PATIENTS FROM METHADONE TO BUPRENORPHINE: THE DEVELOPMENT AND EVALUATION OF PRACTICE GUIDELINES. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2016 Larance, B., Ali, R., Farrell, M., Peacock, A., Bruno, R., Lintzeris, N., . . . Degenhardt, L. (2016). THE IMPACT OF REFORMULATED OXYCONTIN® IN AUSTRALIA: KEY FINDINGS FROM THE NATIONAL OPIOID MEDICATIONS ABUSE DETERRENCE. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2016 McKetin, R., Gardner, J., Baker, A., Dawe, S., Ali, R., Voce, A., . . . Lubman, D. (2016). Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Poster session presented at the meeting of Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2016, as published in Drug and Alcohol Review. Sydney, Australia: Wiley.
DOI
2014 Larance, B., Cama, E., Bruno, R., Farrell, M., Ali, R., Lintzeris, N., . . . Degenhardt, L. (2014). PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2013 Hotham, E., Ali, R., White, J., & Robinson, J. (2013). CONDUCTING RESEARCH WITH PREGNANT SUBSTANCE USERS: SOME CONSIDERATIONS. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2013 White, N., Flaherty, I., Higgs, P., Ali, R., & Lintzeris, N. (2013). EXPERIENCES OF INJECTING BUPRENORPHINE-NALOXONE FILM IN AN AUSTRALIAN COHORT: A QUALITATIVE STUDY. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2013 Larance, B., Lintzeris, N., Ali, R., Mattick, R. P., White, N., Jenkinson, R., . . . Degenhardt, L. (2013). THE DIVERSION AND INJECTION OF BUPRENORPHINE-NALOXONE SUBLINGUAL FILM: 2012 FINDINGS FROM THE AUSTRALIAN POST-MARKETING SURVEILLANCE STUDIES. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2012 Ali, R., & Gowing, L. (2012). SYMPOSIUM - NATIONAL POLICY AND GUIDELINES FOR THE PHARMACOLOGICAL TREATMENT OF OPIOID DEPENDENCE. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2012 Nielsen, S., Larance, B., Black, E., Lintzeris, N., Degenhardt, L., Ali, R., . . . Holland, R. (2012). PAIN PREVALENCE, SEVERITY AND INTERFERENCE IN AN AUSTRALIAN OPIOID AGONIST TREATMENT SAMPLE. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2012 Mcketin, R., Lubman, D. I., Baker, A. L., Dawe, S., & Ali, R. L. (2012). CHANGES IN THE RISK OF PSYCHOTIC SYMPTOMS DURING PERIODS OF METHAMPHETAMINE USE: EVIDENCE FROM A PROSPECTIVE LONGITUDINAL STUDY. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2011 Lintzeris, N., Ali, R., Dunlop, A., Leung, S., & Muhleisen, P. (2011). SYMPOSIUM - MAKING A SWITCH TO SUBOXONE SUBLINGUAL FILM: THE EVIDENCE AND PRACTICAL IMPLICATIONS. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.

Year Citation
2014 Gowing, L., Ali, R., & farrell, M. (2014). Guidance for Community-Based Treatment and Care Services for People Affected by Drug Use and Dependence in Southeast Asia. Thailand: UNODC.
2014 Gowing, L., Ali, R., & farrell, M. (2014). Guidance for Community-Based Treatment and Care Services for People Affected by Drug Use and Dependence in Southeast Asia. Thailand: UNODC.
1999 Brooks, A., Stothard, C., Moss, J., Christie, P., & Ali, R. (1999). Costs associated with the Operation of the Cannabis Expiation Notice Scheme in South Australia (DSC Monograph 5 Research Series).

Year Citation
2015 Authors: Buisman-Pijlman F, Gowing L, Ali R, Salem A. Title: Managing Addiction: A Framework for Successful Treatment. Extent: 5 week course.

Date Role Research Topic Program Degree Type Student Load Student Name
2005 - 2010 Principal Supervisor Treatment Retention in Methadone Maintenance Programs in Indonesia: Towards Evidence-Informed Drug Policy Doctor of Philosophy Doctorate Full Time Mrs Riza Sarasvita
2004 - 2010 Principal Supervisor Investigation of the Alcohol, Smoking and Substance Involvement Screening Test (The ASSIST) in Pregnancy Doctor of Philosophy Doctorate Part Time Ms Elizabeth Dorothy Hotham
1998 - 2002 Co-Supervisor ACUTE PAIN MANAGEMENT IN METHADONE MAINTENANCE TREATMENT Doctor of Philosophy Doctorate Full Time Mr Mark Doverty

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2017 - 2017 Principal Supervisor Are Primary Care and Dosing Regimen Factors in the Outcomes of Injectable Heroin Treatment for Severe Opioid Use Disorder? University of Adelaide International Programme in Addiction Studies Master Full Time Lynda Thorson
2012 - 2016 External Supervisor Economic evaluation comparing the cost-effectiveness of centre based compulsory rehabilitation and voluntary community-based methadone maintenance treatment in Hai Phong City, Vietnam National Drug and Alcohol Research Centre, University of New South Wales - Doctorate Full Time Thu Vuong

Date Role Committee Institution Country
2020 - 2022 Member Reference Group for the Post-market Review of the Opiate Dependence Treatment Program Medicines Department of Health Australian Government Australia
2020 - ongoing Member Expert Advisory Group on Compulsory Facilities for People Who use Drugs Joint UNAIDS-UNODC Thailand
2018 - ongoing Member National Alcohol Treatment Guidelines Advisory Committee University of Sydney Australia
2018 - ongoing Chair NCCRED Methamphetamine and Emerging Drugs: Clinical Research Network NCCRED Australia
2016 - 2020 Member NHMRC Alcohol guidelines committee NHMRC Australia
2014 - ongoing Member Australian National Advisory Council on Alcohol and Drugs - -
2004 - 2014 Board Member Australian National Council on Drugs - -
1998 - 2004 Chair National Expert Advisory Committee on Illicit Drugs - -

Date Role Membership Country
2005 - ongoing Member College on Problems of Drug Dependence -
2004 - ongoing Member International Society of Addiction Medicine -
2000 - ongoing Member Society for the Study of Addiction -
1990 - ongoing Member Australasian Society of HIV Medicine -
1986 - ongoing Member Australian Professional Society on Alcohol & Drugs -

Date Role Editorial Board Name Institution Country
2005 - ongoing Editor Chinese Journal of Drug Dependence - -
2004 - ongoing Associate Editor Drug and Alcohol Dependence - -
2003 - 2016 Editor Drug and Alcohol Review APSAD Australia
1997 - ongoing Editor Cochrane Database of Systematic Reviews - -

Date Office Name Institution Country
2004 - 2014 Asia-Pacific Drug Issues Committee – Chair Australian National Council on Drugs -
2004 - 2007 Chapter Committee – President Australasian Chapter of Addiction Medicine, Royal Australasian College of Physicians -
1996 - 2004 Chair, Board of Continuing Education Australasian Faculty of Public Health Medicine, Royal Australasian College of Physicians -
1988 - 1994 Council Member Australian Professional Society on Alcohol & Drugs Australia

Connect With Me

External Profiles

Other Links